ATE222910T1 - Triptolid-derivate nützlich zur behandlung von autoimmunkrankheiten - Google Patents

Triptolid-derivate nützlich zur behandlung von autoimmunkrankheiten

Info

Publication number
ATE222910T1
ATE222910T1 AT98919928T AT98919928T ATE222910T1 AT E222910 T1 ATE222910 T1 AT E222910T1 AT 98919928 T AT98919928 T AT 98919928T AT 98919928 T AT98919928 T AT 98919928T AT E222910 T1 ATE222910 T1 AT E222910T1
Authority
AT
Austria
Prior art keywords
autoimmune diseases
derivatives useful
treating autoimmune
triptolide derivatives
triptolide
Prior art date
Application number
AT98919928T
Other languages
English (en)
Inventor
Michael J Jung
Mahinda Wickramaratne
Michael Hepperle
Original Assignee
Aventis Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Inc filed Critical Aventis Pharma Inc
Application granted granted Critical
Publication of ATE222910T1 publication Critical patent/ATE222910T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/12Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains three hetero rings
    • C07D493/14Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT98919928T 1997-05-23 1998-04-27 Triptolid-derivate nützlich zur behandlung von autoimmunkrankheiten ATE222910T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US86248897A 1997-05-23 1997-05-23
PCT/US1998/008470 WO1998052951A1 (en) 1997-05-23 1998-04-27 Novel triptolide derivatives useful in the treatment of autoimmune diseases

Publications (1)

Publication Number Publication Date
ATE222910T1 true ATE222910T1 (de) 2002-09-15

Family

ID=25338616

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98919928T ATE222910T1 (de) 1997-05-23 1998-04-27 Triptolid-derivate nützlich zur behandlung von autoimmunkrankheiten

Country Status (20)

Country Link
EP (1) EP0983275B1 (de)
JP (1) JP2001525851A (de)
KR (1) KR20010012822A (de)
CN (1) CN1257507A (de)
AR (1) AR012723A1 (de)
AT (1) ATE222910T1 (de)
AU (1) AU741917B2 (de)
BR (1) BR9809678A (de)
CA (1) CA2287977A1 (de)
DE (1) DE69807466T2 (de)
DK (1) DK0983275T3 (de)
ES (1) ES2178207T3 (de)
HU (1) HUP0003398A3 (de)
IL (1) IL133088A0 (de)
NO (1) NO995723L (de)
NZ (1) NZ500762A (de)
PT (1) PT983275E (de)
TW (1) TW434235B (de)
WO (1) WO1998052951A1 (de)
ZA (1) ZA984174B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6329148B1 (en) 1999-02-16 2001-12-11 The Board Of Trustees Of The Leland Stanford University Combined therapy of diterpenoid triepoxides and death domain receptor ligands for synergistic killing of tumor cells
US6569893B2 (en) * 2001-03-15 2003-05-27 Pharmagenesis, Inc. Amino acid derivatives of triptolide compounds as immune modulators and anticancer agents
JP4680589B2 (ja) * 2002-05-31 2011-05-11 ファーマジェネシス, インコーポレイテッド アポトーシスおよび免疫抑制の調節のためのトリプトリド誘導体
CN100398544C (zh) * 2002-09-18 2008-07-02 成都达远药物有限公司 高免疫抑制活性的水溶性雷公藤内酯醇衍生物及其应用
JP2006513209A (ja) * 2002-12-17 2006-04-20 ファーマジェネシス, インコーポレイテッド 免疫調節因子および抗癌剤としてのトリプトライド誘導体
CN1223595C (zh) 2002-12-27 2005-10-19 中国科学院上海药物研究所 雷公藤内酯醇衍生物及其应用
US6943259B2 (en) * 2003-02-25 2005-09-13 Pharmagenesis, Inc. Halogenated triptolide derivatives as immunomodulators and anticancer agents
US7820834B2 (en) 2003-12-24 2010-10-26 Pharmagenesis, Inc. Triptolide 5,6-derivatives as immunomodulators and anticancer agents
EP1722806A4 (de) 2004-02-09 2009-09-16 Pharmagenesis Inc Verfahren zur isolierung von triptolid-verbindungen aus tripterygium wilfordii
ES2385716T3 (es) 2004-03-02 2012-07-30 Pharmagenesis, Inc. Derivados en el anillo de lactona de triptolida como inmunomoduladores y agentes anticáncer
US20110104186A1 (en) 2004-06-24 2011-05-05 Nicholas Valiante Small molecule immunopotentiators and assays for their detection
US8617906B2 (en) 2004-10-13 2013-12-31 Pharmagenesis, Inc. Identification and screening of triptolide target molecules
AU2010210594B2 (en) * 2009-02-05 2015-02-12 Pharmagenesis, Inc. Triptolide C-ring derivatives as anticancer agents and immune modulators
CN107207525B (zh) * 2015-10-29 2018-11-27 杭州卫本药业有限公司 C14-位羟基酯化的雷公藤甲素氨基酸衍生物、及其制备方法和应用
CN114716503B (zh) * 2022-03-23 2024-03-12 广东省中医院(广州中医药大学第二附属医院、广州中医药大学第二临床医学院、广东省中医药科学院) 一种雷公藤氯内酯醇的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4005108A (en) * 1973-04-03 1977-01-25 Research Corporation Novel anti-leukemic diterpenoid triepoxides
US5430054A (en) * 1989-12-22 1995-07-04 Jiangsu Family Planning Institute Preparation methods of diterpene lactone compounds and application of the same to antifertility
US5663335A (en) * 1996-03-01 1997-09-02 Pharmagenesis, Inc. Immunosuppressive compounds and methods

Also Published As

Publication number Publication date
DK0983275T3 (da) 2002-12-23
BR9809678A (pt) 2000-07-11
CA2287977A1 (en) 1998-11-26
KR20010012822A (ko) 2001-02-26
DE69807466D1 (de) 2002-10-02
AR012723A1 (es) 2000-11-08
JP2001525851A (ja) 2001-12-11
HK1026096A1 (en) 2000-12-01
HUP0003398A2 (en) 2001-03-28
AU7260798A (en) 1998-12-11
WO1998052951A1 (en) 1998-11-26
NO995723D0 (no) 1999-11-22
ZA984174B (en) 1998-11-23
ES2178207T3 (es) 2002-12-16
AU741917B2 (en) 2001-12-13
EP0983275A1 (de) 2000-03-08
TW434235B (en) 2001-05-16
CN1257507A (zh) 2000-06-21
PT983275E (pt) 2003-01-31
HUP0003398A3 (en) 2001-09-28
EP0983275B1 (de) 2002-08-28
DE69807466T2 (de) 2003-04-24
IL133088A0 (en) 2001-03-19
NZ500762A (en) 2001-08-31
NO995723L (no) 2000-01-21

Similar Documents

Publication Publication Date Title
DE69812603D1 (de) Substituierte benzopyranderivate zur behandlung von entzündungen
ATE241977T1 (de) Verwendung von anti-mikrotubuli mitteln zur behandlung von entzündlichen darmerkrankungen
DE69812681D1 (de) Unsubstituierte polydiallylaminen zur behandlung von hypercholesterolemia
DE60019556D1 (de) 2-amino-benzoxazinonderivate zur behandlung von fettleibigkeit
DE69715631D1 (de) Antikonvulsive sulfamatderivate zur behandlung von fettleibigkeit
DE60019555D1 (de) 2-oxy-benzoxazinonderivate zur behandlung von fettleibigkeit
DE69939058D1 (de) Vorrichtung zur behandlung von peripheren gefässerkrankungen
DE59712045D1 (de) Vorrichtung zur behandlung des herzens
NO991955D0 (no) FremgangsmÕte for behandling av hydrokarboner
DE69941280D1 (de) Vorrichtung zur Behandlung von Stenosen an Verzweigungen
ATE200863T1 (de) Indolinonverbindungen zur behandlung von krankheiten
DE69732152D1 (de) Vorrichtung zur Behandlung von Kopfschmerzen
DE69936890D1 (de) Vorrichtung zur Behandlung von Ischämie
NO975690L (no) Fremgangsmåte for forbedring av dyrehelse
DE69714828D1 (de) Verfahren zur Behandlung von Abfallstoffen
DE69806579D1 (de) Anlage zur behandlung von nahrungsmitteln
EP0709090A3 (de) Zusammensetzungen zur Behandlung von resistenten Tumoren
DE69433793D1 (de) Phosphorderivate zur behandlung von aids
ATE222910T1 (de) Triptolid-derivate nützlich zur behandlung von autoimmunkrankheiten
DE69737067D1 (de) Vakzine zur behandlung von mycosen
ATE261434T1 (de) Triptolid-derivate geeignet zur behandlung von autoimmunkrankheiten
IS4789A (is) Meðferðarefnasambönd
DE69721756D1 (de) Paroxetine zur behandlung von depression
DE69729735D1 (de) Verwendung von benzopyranolen zur behandlung von neurologischen erkrankungen
DE59904802D1 (de) Vorrichtung zur Behandlung von Biomolekülen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEIH Change in the person of patent owner